new glp-1 drug retatrutide Retatrutide—A Game Changer in Obesity Pharmacotherapy Will Retatrutide Replace Tirzepatide

& Ingwersen, S

Food and Drug Administration: FDAs Concerns With Unapproved GLP-1 Drugs Used for Weight Loss Harvard Health Publishing: Understanding New Weight Loss Drugs The New England Journal of Medicine : TripleHormone-Receptor Agonist Retatrutide for Obesity a Phase 2 Trial Yale Medicine: GLP-1 Weight-Loss Pills: What You Need to Know FDAs Concerns With Unapproved GLP-1 Drugs Used for Weight Loss

Change (rotate) your injection site within the area you choose with each injection to reduce your risk of getting lumps under the skin (cutaneous amyloidosis)

doi: 10.1007/s00394-021-02770-2 22 MaratheCSRaynerCKJonesKLHorowitzM

K., Lai, H

Practical Reasons: Want Telehealth Convenience The Problem: In-person doctor visits required for Mounjaro prescription No local provider prescribes weight loss medications Dont have time for multiple appointments Prefer virtual healthcare The Solution: Telehealth platforms offering compounded tirzepatide provide complete service online, from consultation through delivery